| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.001 |